Brachytherapy for oligometastatic prostate cancer to the penis

Nicolas Martz; Nicolas Benziane-Ouaritini; Mathieu Gautier; Isabelle Brenot-Rossi; Lucile Montagne; Naji Salem; Yohan Bodokh; Jean-Michel Hannoun-Levi

doi:10.5114/jcb.2021.109754

eISSN: 2081-2841
ISSN: 1689-832X

Journal of Contemporary Brachytherapy

Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links

Editorial System

Submit your Manuscript

5/2021
vol. 13

Send email

Copy url:

abstract:

Case report

Brachytherapy for oligometastatic prostate cancer to the penis

Nicolas Martz

^{1, 2}

,

Nicolas Benziane-Ouaritini

^{1, 3}

,

Mathieu Gautier

¹

,

Isabelle Brenot-Rossi

⁴

,

Lucile Montagne

¹

,

Naji Salem

⁵

,

Yohan Bodokh

^{1, 6}

,

Jean-Michel Hannoun-Levi

¹

Department of Radiation Therapy, Antoine Lacassagne Cancer Center and University of Nice-Sophia, University Cote d’Azur, Nice, France
Department of Radiotherapy, Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France
Department of Radiotherapy, Bergonié Institute, Bordeaux, France
Department of Nuclear Medicine, Paoli Calmettes Institute, Marseille, France
Department of Radiation Therapy, Paoli Calmettes Institute, Marseille, France
Department of Urology, University of Nice Sophia-Antipolis, Hôpital Archet 2, Centre Hospitalier Universitaire de Nice, France

J Contemp Brachytherapy 2021; 13, 5: 593–597

DOI: https://doi.org/10.5114/jcb.2021.109754

Online publish date: 2021/10/06

View full text Get citation

The origin of penile metastases is in 70% of cases from primary pelvic cancers (genitourinary and recto-sigmoid primary tumors). The prognosis is poor and it is often associated with synchronous bone metastases at the time of diagnosis.

We present the case of a 61-year-old patient who developed a penile induration 7 years after radical prostatectomy followed by adjuvant external beam radiation therapy for high-risk prostatic adenocarcinoma. Biopsies confirmed the metastatic localization and a detailed assessment failed to find any further remote lesions. Faced with this penile oligometastatic prostate cancer, we proposed an ablative treatment based on interstitial multi-catheter high-dose rate brachytherapy. At the six-month follow-up, clinical examination and 68Ga-PSMA-11-PET confirmed a complete response of the penile tumor without new lesion at a distance.

keywords:

Brachytherapy for oligometastatic prostate cancer to the penis

Nicolas Martz 1, 2 , Nicolas Benziane-Ouaritini 1, 3 , Mathieu Gautier 1 , Isabelle Brenot-Rossi 4 , Lucile Montagne 1 , Naji Salem 5 , Yohan Bodokh 1, 6 , Jean-Michel Hannoun-Levi 1

prostate cancer, penile cancer, brachytherapy, oligometastasis

Nicolas Martz

^{1, 2}

,

Nicolas Benziane-Ouaritini

^{1, 3}

,

Mathieu Gautier

¹

,

Isabelle Brenot-Rossi

⁴

,

Lucile Montagne

¹

,

Naji Salem

⁵

,

Yohan Bodokh

^{1, 6}

,

Jean-Michel Hannoun-Levi

¹